ArticlePsychopharmacology2026
Social cognition in young adults who endorse a cannabis use disorder.
Article in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleCannabis use disorder (CUD) affects over 50 million people globally. Emerging evidence shows that some people with CUD may experience altered social cognition (e.g., emotion recognition or differentiation). These impairments can affect their ability to understand others' emotional states and navigate social interactions, potentially contributing to chronic cannabis use, even when it leads to interpersonal problems. However, the literature on social cognition in cannabis users is inconsistent, based on a paucity of studies, and characterised by methodological issues including conflation of remitted and current CUD (i.e., does not consider abstinence effects on cognition), limited assessment of cannabis metrics (e.g., dosage) and confounds entrenched with CUD (e.g., nicotine/alcohol use, anxiety). OBJECTIVES/
methodsWe aimed to examine social cognition (i.e., emotion recognition and differentiation, immediate/delayed face memory) in relation to endorsement of CUD (n = 83) vs. controls (n = 32), and measures of level of problematic cannabis use (i.e., Cannabis Use Disorder Identification Test - Revised; CUDIT-R) and dosage (i.e., cannabis grams/past month), accounting for hours since last cannabis use, nicotine/alcohol use, and trait anxiety.
resultsThere were no significant effects of CUD (d = 0-0.314) or dosage and level of problematic cannabis use on social cognition.
conclusionsAltered social cognition may not be a key feature of CUD, or the relationship between CUD and cognition may be moderated by factors such as age, treatment seeking, education, and IQ. In this study, younger age and higher education or IQ may have served as protective factors against social alterations. Replication studies are required to validate this notion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.